Resum
An improved procedure for the synthesis of 3-amino-9-arylsubstituted-thieno[3,2-b]benzothiazine S,S-dioxide 2-decarboxylated is reported. Thieno-[3,2-b]benzothiazine S,S-dioxide derivatives were investigated for their abilities to inhibit β-hematin formation, hemoglobin hydrolysis and in vivo for their efficacy in rodent Plasmodium berghei. Compounds 5j-o were the most promising as inhibitors of hemoglobin hydrolysis, however, the compounds are not as efficient as chloroquine. A structure-activity relationship (SAR) study was carried out in this series. Our results allow us to determine the minimal structural requirements to produce the biological response. © 2008 Elsevier Ltd. All rights reserved.
| Idioma original | Anglès |
|---|---|
| Pàgines (de-a) | 3661-3674 |
| Revista | Bioorganic and Medicinal Chemistry |
| Volum | 16 |
| Número | 7 |
| DOIs | |
| Estat de la publicació | Publicada - 1 d’abr. 2008 |